Cardiology

Multiple factors motivate no reperfusion in STEMI

(HealthDay) -- For patients presenting with ST-segment elevation myocardial infarction (STEMI), the decision for no reperfusion is usually multifactorial, with the most common factor being advanced age, according to a study ...

Cardiology

Drug-Eluting stents offer no advantage for A-Fib patients

(HealthDay) -- Drug-eluting stents (DESs) do not seem to offer advantages over bare-metal stents (BMSs) for patients with atrial fibrillation (AF) who undergo percutaneous coronary intervention (PCI) with stent implantation, ...

Cardiology

Good long-term outcomes for drug-eluting stents

(HealthDay) -- Meta-analysis of randomized clinical trials (RCTs) suggests that drug-eluting stents (DESs) significantly reduce repeat revascularizations, with no increase in stent thrombosis (ST), mortality, or recurrent ...

Cardiology

Argentina heart attack death rate nearly halved over 15 years

The 38th Argentine Congress of Cardiology takes place 5 to 7 October 2012 in Buenos Aires, Argentina. The event is organised by the Argentine Society of Cardiology, which is an affiliated member of the European Society of ...

page 4 from 5